ArticleFrontiers in psychiatry2025
Solution-focused brief therapy for common mental disorders in the light of empirically supported treatment revised criteria: a systematic review protocol.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Solution-Focused Brief Therapy (SFBT) is a short-term, goal-directed therapeutic approach widely used across diverse settings. While prior evidence supports its overall effectiveness, the empirical status of SFBT as a treatment for common mental disorders (CMD) remains unclear. This protocol outlines a systematic review aiming to evaluate the efficacy, effectiveness, mechanisms of change, and cost-effectiveness of SFBT in the treatment of CMD following the updated empirically supported treatment criteria. Methods: A systematic search for recently published systematic reviews, randomized controlled trials, and high-quality non-randomized studies of intervention examining SFBT in adults (≥18 years) diagnosed with CMDs will be performed. Risk of bias and methodological quality will be assessed. Data selection, extraction, and rating will be conducted independently by at least two reviewers. Outcomes: Primary outcomes include symptom reduction in CMD; secondary outcomes encompass, among other improvements in psychosocial functioning and remission rates. Additional outcomes involve cost-effectiveness, adverse effects, and evidence for mechanisms of change. Meta-analysis and narrative synthesis will be performed when appropriate. Expected Impact: The rigorous assessment of SFBT empirical status in the context of CMD can potentially influence recommendations for clinical practice, guideline development, and future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.